Stocks and Investing Stocks and Investing
Mon, November 14, 2022
[ 12:00 AM ] - WOPRAI
John Murphy Maintained (TSLA) at Hold with Decreased Target to $275 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Michael Leithead Maintained (TSE) at Hold with Increased Target to $25 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (TPG) at Hold with Increased Target to $30 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Paul Lejuez Maintained (TPR) at Strong Buy with Decreased Target to $40 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Phani Kanumuri Upgraded (TIGO) to Hold on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Scott Hanold Maintained (SM) at Hold with Increased Target to $55 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
David Gagliano Maintained (STLD) at Hold with Increased Target to $100 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Nicholas Zangler Initiated (STGW) at Buy and Held Target at $10 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Krisztina Katai Maintained (SPTN) at Hold with Decreased Target to $35 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Jay Olson Maintained (BIIB) at Buy with Increased Target to $315 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Amit Dayal Upgraded (BEEM) to Strong Buy on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Robin Farley Maintained (CCL) at Strong Buy with Increased Target to $16 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Sorabh Daga Downgraded (CCU) to Hold and Decreased Target to $13 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Brian Nowak Maintained (COMP) at Hold with Decreased Target to $4 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Chris Schott Downgraded (TEVA) to Sell and Decreased Target to $10 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Shyam Patil Maintained (TBLA) at Hold with Decreased Target to $2.25 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Eric Sheridan Maintained (XMTR) at Strong Buy with Decreased Target to $57 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Jay Sole Maintained (WWW) at Hold with Decreased Target to $15 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Jerry Revich Maintained (XOS) at Hold with Decreased Target to $72 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Bruno Amorim Maintained (YPF) at Strong Sell with Increased Target to $5.1 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Joseph Stringer Maintained (STOK) at Strong Buy with Decreased Target to $25 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Kevin Steinke Maintained (SUP) at Buy with Decreased Target to $19 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Michael Mueller Maintained (VTR) at Hold with Decreased Target to $48 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Adam Samuelson Maintained (VITL) at Hold with Increased Target to $15 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Jeffrey Spector Upgraded (VRE) to Hold and Increased Target to $18 on, Nov 14th, 2022
[ 12:00 AM ] - WOPRAI
Matthew Biegler Maintained (VOR) at Buy with Decreased Target to $18 on, Nov 14th, 2022
Fri, November 11, 2022
[ 12:00 AM ] - WOPRAI
Steve Sakwa Maintained (VNO) at Hold with Decreased Target to $28 on, Nov 11th, 2022
[ 12:00 AM ] - WOPRAI
Michael Lewis Maintained (VNO) at Strong Buy with Decreased Target to $28 on, Nov 11th, 2022
[ 12:00 AM ] - WOPRAI
Carter Gould Maintained (VOR) at Buy with Decreased Target to $15 on, Nov 11th, 2022
[ 12:00 AM ] - WOPRAI
Gregory Renza Maintained (VIRX) at Buy with Decreased Target to $8 on, Nov 11th, 2022

Gregory Renza Maintained (VIRX) at Buy with Decreased Target to $8 on, Nov 11th, 2022


Published on 2024-10-28 00:08:14 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Maintained "Viracta Therapeutics, Inc." (VIRX) at Buy with Decreased Target from $10 to $8 on, Nov 11th, 2022.

Gregory has made no other calls on VIRX in the last 4 months.



There is 1 other peer that has a rating on VIRX. Out of the 1 peers that are also analyzing VIRX, 0 agree with Gregory's Rating of Hold.



This is the rating of the analyst that currently disagrees with Gregory

  • Andrew Berens of "SVB Securities" Maintained at Buy and Held Target at $11 on, Thursday, November 10th, 2022
Contributing Sources